Medscape Hematology-Oncology Headlines 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.US FDA Mandates Label Updates on CAR-T Cancer Therapies US FDA Mandates Label Updates on CAR-T Cancer Therapies
The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called " boxed warning " to highlight the...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Immunotherapy and Targeted Therapy Regimens for Melanoma Immunotherapy and Targeted Therapy Regimens for Melanoma
Dr Jeffrey Weber discusses recent abstracts focused on melanoma, as presented at ESMO.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
ESMO : Breakthroughs in Melanoma Treatment Regimens ESMO : Breakthroughs in Melanoma Treatment Regimens
Dr Jeffrey Weber discusses recent abstracts focused on melanoma, as presented at ESMO.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Cancer Stage vs Mortality Endpoints in Screening Trials? Cancer Stage vs Mortality Endpoints in Screening Trials?
In clinical trials of cancer screening, the incidence of late-stage cancer works as well as cancer-specific mortality as an endpoint for some cancers but not others.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
Can DNA Tests Promote Colorectal Cancer Screening? Can DNA Tests Promote Colorectal Cancer Screening?
Colorectal cancer screening remains inadequate in France, but DNA tests could enable screening through a simple blood test or stool analysis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Certain Women May Face Higher Risk for Second Breast Cancer Certain Women May Face Higher Risk for Second Breast Cancer
Young breast cancer survivors with a germline pathogenic variant or who are initially diagnosed with in situ disease have more than a fourfold higher risk for a second primary breast cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 17, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
Microbial Signature of KRAS-Mutated CRC Identified Microbial Signature of KRAS-Mutated CRC Identified
Researchers analyzed gut microbiota from KRAS-mutated and KRAS wild-type colorectal cancer to assess the link between disruptions in the gut microbiome and KRAS mutations in the disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 17, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
New Agent Shows Early Promise in Triple-Class Refractory MM New Agent Shows Early Promise in Triple-Class Refractory MM
With linvoseltamab and other bispecific antibodies inducing deep and durable responses, there might finally be a go-to option for multiple myeloma patients resistant to mainstay treatments.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 17, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Monitoring ctDNA Predicts HER2+ Cancer Treatment Response Monitoring ctDNA Predicts HER2+ Cancer Treatment Response
Tracking a patient ' s circulating tumor DNA (ctDNA) can offer insight into how well-targeted therapies work in the early stages of treatment for HER2-positive cancers.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 15, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Is Axillary Surgery in Early Breast Cancer on Its Way Out? Is Axillary Surgery in Early Breast Cancer on Its Way Out?
Omitting axillary surgery in patients with early breast cancer who had sentinel-node metastases and underwent surgery and radiotherapy did not compromise survival outcomes, new data show.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 15, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
Review Suggests Skin AEs Rare With PD-1/PD-L1 Inhibitors Review Suggests Skin AEs Rare With PD-1/PD-L1 Inhibitors
Reports of keratoacanthomas and squamous cell carcinomas associated with the use of PD-1/PD-L1 inhibitors appeared to be relatively rare.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 15, 2024 Category: Cancer & Oncology Tags: Dermatology Clinical Summary Source Type: news
Will AI Clinical Notes Benefit Your Practice? Will AI Clinical Notes Benefit Your Practice?
Artificial intelligence expert Arturo Loaiza-Bonilla, MD, discusses the benefits of AI-based clinical notes.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Oncologists Voice Ethical Concerns Over AI in Cancer Care Oncologists Voice Ethical Concerns Over AI in Cancer Care
A survey of oncologists highlighted ethical issues over the use of AI in cancer care and revealed some contradictory views about how best to integrate these tools.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
No Routine Cancer Screening Option? New MCED Tests May Help No Routine Cancer Screening Option? New MCED Tests May Help
Early data suggest that several new multicancer early detection tests can identify a range of cancers that lack routine screening options.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Further Support for CRC Screening to Start at Age 45 Further Support for CRC Screening to Start at Age 45
Adenoma detection rates were shown to be comparable between 45-49-year-olds and 50-54-year-olds.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2024 Category: Cancer & Oncology Tags: Gastroenterology Clinical Summary Source Type: news
